The 2 analysts offering 1 year price forecasts for UR9 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings to UR9 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
UR9 EPS for the last quarter is 0.13 EUR despite the estimation of 0.16 EUR. In the next quarter EPS is expected to reach 0.25 EUR. Track more of CLINUVEL PHARMACEUTICALS LTD financials and stay on top of what is up with the company.
According to analysts, UR9 price target is 16.63 EUR with a max estimate of 19.46 EUR and a min estimate of 13.80 EUR. Check if this forecast comes true in a year, meanwhile watch CLINUVEL PHARMACEUTICALS LTD stock price chart and keep track of the current situation with UR9 news and stock market news.